| 04/22/2026 7:54 AM | Franklin Covey (886206) Subject ROYCE & ASSOCIATES LP (906304) Filed by | Form SCHEDULE 13G | |
| 04/08/2026 3:44 PM | Franklin Covey (886206) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 04/08/2026 1:35 PM | Franklin Covey (886206) Issuer WHITMAN ROBERT A (1017012) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/01/2026 3:19 PM | Franklin Covey (886206) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/26/2026 5:39 PM | Franklin Covey (886206) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 03/18/2026 3:20 PM | Franklin Covey (886206) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/30/2026 11:02 AM | Franklin Covey (886206) Issuer WHITMAN ROBERT A (1017012) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/27/2026 12:51 PM | Franklin Covey (886206) Issuer MCNAMARA DONALD J (1017011) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/27/2026 12:55 PM | Franklin Covey (886206) Issuer VAN BEVER DEREK C M (1208406) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/27/2026 12:58 PM | Franklin Covey (886206) Issuer RIVERA EFRAIN (1188736) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/27/2026 1:00 PM | Franklin Covey (886206) Issuer Phillips Nancy R (1438251) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for FC and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Franklin Covey and its competitors with MarketBeat's FREE daily newsletter.
|
| 01/26/2026 9:49 AM | Franklin Covey (886206) Subject ROYCE & ASSOCIATES LP (906304) Filed by | Form SCHEDULE 13G/A | |
| 01/23/2026 1:33 PM | Franklin Covey (886206) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/09/2026 3:14 PM | Franklin Covey (886206) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 01/07/2026 3:16 PM | Franklin Covey (886206) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/22/2025 3:16 PM | Franklin Covey (886206) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/19/2025 5:05 AM | Franklin Covey (886206) Filer | Form ARS | |
| 12/18/2025 3:32 PM | Franklin Covey (886206) Filer | Form DEF 14A | |
| 11/25/2025 1:41 PM | Covey Michael Sean Merrill (1446558) Reporting Franklin Covey (886206) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/25/2025 1:45 PM | Dom Colleen D (1587704) Reporting Franklin Covey (886206) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/25/2025 1:48 PM | Franklin Covey (886206) Issuer Hatch Anthony Derek (2068362) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/25/2025 1:50 PM | Franklin Covey (886206) Issuer Procter Holly (2083098) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/25/2025 1:52 PM | Franklin Covey (886206) Issuer Walker Paul S (1653286) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/25/2025 1:55 PM | Franklin Covey (886206) Issuer WHITMAN ROBERT A (1017012) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/24/2025 9:57 AM | Franklin Covey (886206) Filer | Form 8-K/A | |
| 11/17/2025 5:02 PM | Covey Michael Sean Merrill (1446558) Reporting Franklin Covey (886206) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/17/2025 5:06 PM | Franklin Covey (886206) Issuer Hatch Anthony Derek (2068362) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/17/2025 5:09 PM | Franklin Covey (886206) Issuer Procter Holly (2083098) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/17/2025 5:11 PM | Franklin Covey (886206) Issuer Walker Paul S (1653286) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/17/2025 5:16 PM | Betjemann Jessica (1878428) Reporting Franklin Covey (886206) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/17/2025 5:18 PM | Dom Colleen D (1587704) Reporting Franklin Covey (886206) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/14/2025 10:37 AM | ALLIANCEBERNSTEIN L.P. (1109448) Filed by Franklin Covey (886206) Subject | Form SCHEDULE 13G | |
| 11/12/2025 1:08 PM | Dom Colleen D (1587704) Reporting Franklin Covey (886206) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/05/2025 3:20 PM | Franklin Covey (886206) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/22/2025 3:25 PM | Franklin Covey (886206) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/09/2025 5:26 PM | Covey Michael Sean Merrill (1446558) Reporting Franklin Covey (886206) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/09/2025 3:38 PM | Franklin Covey (886206) Issuer Procter Holly (2083098) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 07/14/2025 6:50 PM | Franklin Covey (886206) Issuer Hatch Anthony Derek (2068362) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/14/2025 6:52 PM | Franklin Covey (886206) Issuer Walker Paul S (1653286) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/14/2025 6:56 PM | Colosimo Jennifer C. (1446503) Reporting Franklin Covey (886206) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/14/2025 6:58 PM | Dom Colleen D (1587704) Reporting Franklin Covey (886206) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
NNVC FDA = New Momentum Wave! (Ad) NanoViricides (NYSE: NNVC) just received FDA Orphan Drug Designation for its antiviral NV-387, targeting measles at a time when no approved antiviral treatments exist and cases are resurging globally.
Beyond measles, NV-387 is designed as a broad-spectrum platform targeting RSV, influenza, coronaviruses, Mpox, and more - giving NNVC exposure to multiple large markets as Phase II trials advance. See why this FDA milestone could be a catalyst for NNVC |
| 07/14/2025 6:44 PM | Covey Michael Sean Merrill (1446558) Reporting Franklin Covey (886206) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/14/2025 6:47 PM | Betjemann Jessica (1878428) Reporting Franklin Covey (886206) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/08/2025 3:28 PM | Franklin Covey (886206) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 07/02/2025 3:20 PM | Franklin Covey (886206) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/18/2025 3:30 PM | Franklin Covey (886206) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/19/2025 6:06 PM | Franklin Covey (886206) Issuer Hatch Anthony Derek (2068362) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 05/14/2025 4:04 PM | ALLIANCEBERNSTEIN L.P. (1109448) Filed by Franklin Covey (886206) Subject | Form SCHEDULE 13G/A | |